Zinc finger protein transcription factor to inhibit alpha-synuclein expression

摘要

The present invention provides a zinc finger fusion protein that inhibits the expression of alpha-synuclein in the nervous system, and a method for treating Parkinson's disease, Lewy body dementia, multiple system atrophy, Alzheimer's disease, and other neurodegenerative diseases using the protein do.